Martin Haluzík Selected Research

prolactin-releasing peptide receptor

1/2016

Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Haluzík Research Topics

Disease

25	Type 2 Diabetes Mellitus (MODY) 03/2022 - 09/2009
23	Obesity 01/2022 - 09/2006
16	Body Weight (Weight, Body) 03/2022 - 09/2008
10	Inflammation (Inflammations) 01/2021 - 11/2009
7	Hypoglycemia (Reactive Hypoglycemia) 03/2022 - 01/2013
7	Insulin Resistance 09/2020 - 09/2008
4	Weight Gain 01/2022 - 01/2012
4	Weight Loss (Weight Reduction) 01/2022 - 12/2014
4	Rheumatoid Arthritis 10/2013 - 07/2010
3	Pheochromocytoma 03/2022 - 04/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 11/2009
3	Anorexia Nervosa 01/2018 - 09/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 12/2016
3	Hyperglycemia 12/2017 - 09/2006
2	Paraganglioma (Paragangliomas) 03/2022 - 04/2019
2	Non-alcoholic Fatty Liver Disease 12/2021 - 11/2009
2	Heart Failure 01/2021 - 12/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 09/2014
2	Neoplasms (Cancer) 04/2019 - 11/2009
2	Critical Illness (Critically Ill) 01/2018 - 01/2011
2	Short Bowel Syndrome 01/2018 - 02/2002
2	Diabetes Mellitus 12/2017 - 09/2014
2	Dyslipidemias (Dyslipidemia) 12/2016 - 05/2012
2	Atherosclerosis 05/2012 - 11/2009
2	Chronic Renal Insufficiency 08/2010 - 11/2009
1	Glycosuria 01/2022
1	Gilbert Disease 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Fatty Liver 12/2021
1	Atrial Fibrillation 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020
1	Body Weight Changes 01/2020
1	Prediabetic State (Prediabetes) 01/2020
1	Glucose Intolerance 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Gliosis 01/2019
1	Cushing Syndrome 01/2019

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 09/2009
10	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 12/2014
9	Insulin (Novolin)FDA Link 02/2022 - 09/2008
9	AdipokinesIBA 12/2021 - 07/2010
7	LipidsIBA 10/2020 - 12/2014
7	LeptinIBA 01/2020 - 09/2006
6	Liraglutide FDA Link 01/2022 - 01/2015
6	CytokinesIBA 11/2021 - 08/2010
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 12/2014
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022 - 07/2015
4	insulin degludecIBA 01/2020 - 01/2018
4	C-Reactive ProteinIBA 01/2019 - 09/2009
4	Sodium Glutamate (Accent)IBA 01/2016 - 09/2006
3	semaglutideIBA 01/2022 - 01/2019
3	Hormones (Hormone)IBA 09/2020 - 01/2010
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2013
3	Insulin Glargine (Lantus)FDA Link 01/2020 - 01/2019
3	palm11-PrRP31IBA 01/2020 - 01/2018
3	Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA 01/2018 - 01/2016
3	AdiponectinIBA 01/2016 - 09/2008
2	CatecholaminesIBA 03/2022 - 01/2011
2	IDegLiraIBA 01/2020 - 01/2019
2	VildagliptinIBA 05/2019 - 01/2016
2	Metformin (Glucophage)FDA LinkGeneric 05/2019 - 01/2016
2	fibroblast growth factor 21IBA 04/2019 - 09/2008
2	EnzymesIBA 01/2019 - 01/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 04/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
2	InsulinsIBA 12/2017 - 09/2014
2	HDL CholesterolIBA 01/2017 - 09/2009
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 09/2009
2	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 01/2017
2	CholesterolIBA 01/2017 - 10/2013
2	NeuropeptidesIBA 01/2016 - 09/2006
2	IncretinsIBA 12/2014 - 01/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012 - 01/2011
2	GhrelinIBA 01/2010 - 02/2002
1	neutral insulin FDA Link 03/2022
1	insulin aspart drug combination insulin degludecIBA 02/2022
1	BilirubinIBA 12/2021
1	Uridine Diphosphate (UDP)IBA 12/2021
1	TransferasesIBA 12/2021
1	Heme Oxygenase-1IBA 12/2021
1	dapagliflozinIBA 01/2021
1	empagliflozinIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	MetanephrineIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2011
5	Bariatric Surgery 01/2021 - 01/2016
3	Glycemic Control 03/2022 - 01/2011
3	Caloric Restriction 01/2018 - 09/2009
1	Gastrectomy 01/2021
1	Catheter Ablation 01/2021
1	Preconception Care 01/2021
1	Oral Administration 05/2019
1	Injections 01/2019